MyAverix Finance
BR · Healthcare
Hyloris Developmentsen Sa (HYL)
Biotechnology
Hyloris Developmentsen Sa (HYL) is listed on BR in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $139.72M, P/E ratio is 25.00, net margin is -71.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HYL
Hyloris Developmentsen Sa (HYL) — FAQ
What is Hyloris Developmentsen Sa's market cap?
Hyloris Developmentsen Sa (HYL) has a reported market cap of $139.72M (data as of 2026-05-24).
What is HYL's P/E ratio?
The price-to-earnings (P/E) ratio for Hyloris Developmentsen Sa (HYL) is 25.00 (data as of 2026-05-24).
Does Hyloris Developmentsen Sa pay a dividend?
Dividend yield is not available in the current snapshot for Hyloris Developmentsen Sa (HYL). Check the MyAverix Finance app for the latest dividend data.
What sector is Hyloris Developmentsen Sa in?
Hyloris Developmentsen Sa (HYL) is classified in the Healthcare sector (Biotechnology industry).
What exchange is HYL listed on?
HYL is listed on BR.
What is Hyloris Developmentsen Sa's net margin?
Hyloris Developmentsen Sa (HYL) reports a net margin of -71.7% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.